Cefadroxil
Application Notes
Cefadroxil was used to investigate its interaction with hPEPT1 and dipeptide Gly-Sar on basis of steady-state and presteady-state analysis thus testing the hypothesis that variations in drug response among individuals are caused by alterations in the genes involved in drug absorption.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Antibiotic
| SKU | 02150581-CF |
| Alternate Names | p-Hydroxycephalexine; Cefamox |
| Application Notes | Cefadroxil was used to investigate its interaction with hPEPT1 and dipeptide Gly-Sar on basis of steady-state and presteady-state analysis thus testing the hypothesis that variations in drug response among individuals are caused by alterations in the genes involved in drug absorption. |
| Base Catalog Number | 150581 |
| CAS # | 50370-12-2 |
| EC Number | 256-555-6 |
| Format | White powder |
| Hazard Statements | H315-H317-H319-H334-H335 |
| Melting Point | 197 °C |
| Molecular Formula | C16H17N3O5S |
| Molecular Weight | 363.388 g/mol |
| Personal Protective Equipment | Dust mask, Eyeshields, Faceshields, Gloves |
| Potency | No tenative range given |
| RTECS Number | XI0337000 |
| Safety Symbol | GHS07, GHS08 |
| Solubility | Water Solubility1110 mg/L |
| Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |